AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines
Committee provides periodic reviews of new data to produce focused updates that address …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Atrial fibrillation (AF) is the most common sustained arrhythmia and is associated with
substantial morbidity and impairment of quality of life. Restoration and maintenance of …

Background Guidelines recommend that initial trial of a “pill-in-the-pocket”(PIP) Class 1C
antiarrhythmic drug (AAD) for cardioversion of atrial fibrillation (AF) be performed in a …

Study objective We conduct a systematic review and Bayesian network meta-analysis to
indirectly compare and rank antidysrhythmic drugs for pharmacologic cardioversion of …

Transcatheter ablation was increasingly and successfully used to treat symptomatic drug
refractory patients affected by supraventricular arrhythmias. Antiarrhythmic drug treatment …

В настоящем документе представлены актуальные на сегодняшний день
рекомендации по диагностике и лечению фибрилляции предсердий (ФП) …

The therapy of atrial fibrillation often involves the use of a rhythm control strategy, in which 1
or more antiarrhythmic drugs (AAD), ablative procedures, and/or hybrid approaches …

Background The negative inotropic effect of Class IC antiarrhythmic drugs limits their use for
acute cardioversion of atrial fibrillation (AF). Objective The purpose of this study was to …